155 related articles for article (PubMed ID: 26187895)
1. Direct uptake of Antagomirs and efficient knockdown of miRNA in primary B and T lymphocytes.
Haftmann C; Riedel R; Porstner M; Wittmann J; Chang HD; Radbruch A; Mashreghi MF
J Immunol Methods; 2015 Nov; 426():128-33. PubMed ID: 26187895
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo.
Maschmeyer P; Petkau G; Siracusa F; Zimmermann J; Zügel F; Kühl AA; Lehmann K; Schimmelpfennig S; Weber M; Haftmann C; Riedel R; Bardua M; Heinz GA; Tran CL; Hoyer BF; Hiepe F; Herzog S; Wittmann J; Rajewsky N; Melchers FG; Chang HD; Radbruch A; Mashreghi MF
J Autoimmun; 2018 May; 89():41-52. PubMed ID: 29183643
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional oligodeoxynucleotide/antagomiR constructs: evaluation of a new tool for microRNA silencing.
Ziegler S; Eberle ME; Wölfle SJ; Heeg K; Bekeredjian-Ding I
Nucleic Acid Ther; 2013 Dec; 23(6):427-34. PubMed ID: 24236889
[TBL] [Abstract][Full Text] [Related]
4. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
5. Specificity, duplex degradation and subcellular localization of antagomirs.
Krützfeldt J; Kuwajima S; Braich R; Rajeev KG; Pena J; Tuschl T; Manoharan M; Stoffel M
Nucleic Acids Res; 2007; 35(9):2885-92. PubMed ID: 17439965
[TBL] [Abstract][Full Text] [Related]
6. Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo.
Su YL; Swiderski P; Marcucci G; Kortylewski M
Methods Mol Biol; 2019; 1974():141-150. PubMed ID: 31099000
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal control of microRNA function using light-activated antagomirs.
Connelly CM; Uprety R; Hemphill J; Deiters A
Mol Biosyst; 2012 Nov; 8(11):2987-93. PubMed ID: 22945263
[TBL] [Abstract][Full Text] [Related]
8. A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA.
Suryawanshi H; Sarangdhar MA; Vij M; Roshan R; Singh VP; Ganguli M; Pillai B
J Vis Exp; 2015 Dec; (106):e53307. PubMed ID: 26779762
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.
Scherr M; Venturini L; Battmer K; Schaller-Schoenitz M; Schaefer D; Dallmann I; Ganser A; Eder M
Nucleic Acids Res; 2007; 35(22):e149. PubMed ID: 18025036
[TBL] [Abstract][Full Text] [Related]
10. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim.
Haftmann C; Stittrich AB; Zimmermann J; Fang Z; Hradilkova K; Bardua M; Westendorf K; Heinz GA; Riedel R; Siede J; Lehmann K; Weinberger EE; Zimmel D; Lauer U; Häupl T; Sieper J; Backhaus M; Neumann C; Hoffmann U; Porstner M; Chen W; Grün JR; Baumgrass R; Matz M; Löhning M; Scheffold A; Wittmann J; Chang HD; Rajewsky N; Jäck HM; Radbruch A; Mashreghi MF
Eur J Immunol; 2015 Apr; 45(4):1192-205. PubMed ID: 25486906
[TBL] [Abstract][Full Text] [Related]
11. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.
Lu Y; Hippen KL; Lemire AL; Gu J; Wang W; Ni X; Ranganathan P; Levine BL; Riley JL; June CH; Turka LA; Munn DH; Garzon R; Lu L; Blazar BR
Blood; 2016 Sep; 128(10):1424-35. PubMed ID: 27485827
[TBL] [Abstract][Full Text] [Related]
12. Cardiac injections of AntagomiRs as a novel tool for knockdown of miRNAs during heart development.
Wittig JG; Billmeier M; Lozano-Velasco E; García MR; Münsterberg AE
Dev Biol; 2019 Jan; 445(2):163-169. PubMed ID: 30496744
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.
Plank MW; Maltby S; Tay HL; Stewart J; Eyers F; Hansbro PM; Foster PS
PLoS One; 2015; 10(12):e0144810. PubMed ID: 26693910
[TBL] [Abstract][Full Text] [Related]
14. Identification of Differentially Expressed miRNAs in the Response of Spleen CD4
Liu J; Liu J; Xiao L; Wang Y; Liu G; Li J; Liang F
Cell Biochem Biophys; 2020 Mar; 78(1):89-100. PubMed ID: 32026263
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different chemically modified inhibitors of miR-199b in vivo.
Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
[TBL] [Abstract][Full Text] [Related]
16. Utilizing antagomiR (antisense microRNA) to knock down microRNA in murine bone marrow cells.
Velu CS; Grimes HL
Methods Mol Biol; 2012; 928():185-95. PubMed ID: 22956143
[TBL] [Abstract][Full Text] [Related]
17. Control of oncogenic miRNA function by light-activated miRNA antagomirs.
Connelly CM; Deiters A
Methods Mol Biol; 2014; 1165():99-114. PubMed ID: 24839022
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells.
Okoye IS; Coomes SM; Pelly VS; Czieso S; Papayannopoulos V; Tolmachova T; Seabra MC; Wilson MS
Immunity; 2014 Jul; 41(1):89-103. PubMed ID: 25035954
[TBL] [Abstract][Full Text] [Related]
19. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
20. Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.
Fabani MM; Abreu-Goodger C; Williams D; Lyons PA; Torres AG; Smith KG; Enright AJ; Gait MJ; Vigorito E
Nucleic Acids Res; 2010 Jul; 38(13):4466-75. PubMed ID: 20223773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
